The Motley Fool··David Jagielski, CpaAbbVie Stock Trades at Bargain Valuation as New Drugs Offset Humira Decline
AbbVie stock down 11% YTD but trades at 14x forward P/E with 0.49 PEG, suggesting undervaluation amid strong new drug momentum and 3.4% dividend yield.
ABBVXLVdividend yieldhealthcare stocks